Poor clinical outcome of relapsed/refractory diffuse large B-cell lymphoma with MYC translocation treated with polatuzumab vedotin, bendamustine, and rituximab
JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY(2023)
关键词
diffuse large B-cell lymphoma,polatuzumab vedotin,bendamustine,MYC translocation
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要